Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHL Telemedicine | Switzerland | Healthcare | Healthcare Providers & Services | CHF 49.17M | -8.1x | 0.81 | CHF 3 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Groupe Minoteries SA | Switzerland | Consumer Non-Cyclicals | Food & Tobacco | CHF 73.92M | 11.8x | -0.63 | CHF 224 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BVZ Holding AG | Switzerland | Industrials | Passenger Transportation Services | CHF 181.50M | 8x | -0.56 | CHF 920 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CI Com SA | Switzerland | Financial | Investment Holding Companies | CHF 780K | -0.4x | 0 | CHF 1.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bergbahnen Engelberg Truebsee | Switzerland | Industrials | Passenger Transportation Services | CHF 135.07M | 13.1x | 0.06 | CHF 40.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.4% Upside | Upgrade to Pro+ | |
Joincare Pharmaceutical DRC | Switzerland | Healthcare | Pharmaceuticals | CHF 2.29B | 13.4x | -2.09 | CHF 7.27 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plazza Immobilien AG | Switzerland | Real Estate | Real Estate Operations | CHF 660.33M | 36.1x | CHF 319 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Addex Therapeutics Ltd | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 6.98M | -0.5x | -0.01 | CHF 0.07 | -13.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Helvetia | Switzerland | Financial | Insurance | CHF 7.21B | 26.5x | -0.6 | CHF 136.50 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.4% Downside | Upgrade to Pro+ | |
Spexis | Switzerland | Healthcare | Pharmaceuticals | CHF 3.38M | -0.2x | -0.05 | CHF 0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Relief Therapeutics | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 26.33M | -0.6x | -0.01 | CHF 2.10 | -10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |